Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (SRRK)

CUSIP: 80706P103

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+27,000,752
Put/Call ratio
3.3%
SEC-reported price per share
$18.80
Number of holders
132
Value change
+$517,112,415
Number of buys
111
Open additional details 1 more signal available
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
119,752,556

Security key

80706P103

Report period

Q4 2023

Institutions

132

Top holders

10

Ownership snapshot

Top reported holders of SRRK - Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Samsara BioCapital GP, LLC
Disclosed value leader
Samsara BioCapital GP, LLC
Comparable rows
0/15
Latest evidence
16 Oct 2023
3/4/5 13F Highest disclosed value: $108,133,716 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Samsara BioCapital GP, LLC has the largest disclosed position value at $108.13M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Samsara BioCapital GP, LLC's linked filing trail.
Disclosed position value Top 5
Samsara BioCapital GP, LLC $108.13M
Artal Group S.A. $64.32M
FMR LLC $56.84M
PRICE T ROWE ASSOCIATES INC /MD/ $50.92M
Redmile Group, LLC $33.61M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Samsara BioCapital GP, LLC
3/4/5
10%+ Owner
—
denominator unverified
$108,133,716
6,788,609 shares
— 16 Oct 2023
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$64,322,000
9,059,507 shares
— 30 Sep 2023
FMR LLC
13F
Company
13F
—
denominator unverified
$56,840,144
8,005,654 shares
— 30 Sep 2023
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$50,922,000
7,171,952 shares
— 30 Sep 2023
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$33,606,061
4,733,248 shares
— 30 Sep 2023
Samsara BioCapital, LLC
13F
Company
13F
—
denominator unverified
$32,651,679
4,598,828 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
132
Shares
80,943,926
Rows available
132
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
88
Q4 2023 holders
132
Holder diff
44
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .